ACADEMIA

• Arzerra, Japan’s 1st Antibody for CLL, Will Expand Treatment Options: Dr Ogawa of Tokai Univ.
  July 11, 2013

• Nearly 30% of RA Patients Show LDA 3 Years After Discontinuing Remicade: Prof. Tanaka of Univ. of Occupational and Environmental Health
  July 11, 2013

• Orencia Particularly Suitable for Elderly RA Patients: Prof. Takeuchi of Keio University
  July 8, 2013

• “No Data Manipulation” in VART Study of Diovan: Interim Report of Japanese Society of Hypertension
  July 4, 2013

• NHO Attains 30% Volume-Based Generic Target in FY2012
  June 28, 2013

• JSOG Sets Up Investigative Panel on HPV Vaccines to Examine Safety
  June 26, 2013

• Dapagliflozin Significantly Reduces Plasma Glucose in PIII Study in Japan, Findings Reported at ADA
  June 25, 2013

• SCJ Statement Calls for Close Consultation with Experts in Planning Japanese Version of NIH
  June 25, 2013

• Makers Should Venture into Drug Development Using iPS, CiRA Adviser Asonuma Says
  June 25, 2013

• More Treatment Options for FD Patients with Acofide Launch: Prof. Kinoshita of Shimane University
  June 11, 2013

• Clinical Pharmacology Network to Go Into Operation with 8 Institutions
  June 6, 2013

• Japan College of Rheumatology Issues Guidelines on Xeljanz Use
  June 6, 2013

• Cetuximab Add-on Therapy Fails to Improve PFS in Operable Colorectal Liver Metastasis Patients: ASCO　
  June 4, 2013

• Japan College of Rheumatology to Collaborate with Pfizer on PMS, Warns that Non-RA Specialists More Inclined to Prescribe Xeljanz
  May 31, 2013

• Researcher Wearing Two Hats Should Disclose Affiliation with Greater Interests in Trials: Japan Hypertension Society　
  May 30, 2013

• JAMS Recognizes Violation of COI Reporting Rules over Diovan Papers
  May 28, 2013

• Nat’l University Hospitals Sharing Information of Drug Purchase Prices through Central Database
  May 7, 2013

• JAMS Greatly Concerned Over Diovan Paper Retractions: President Takaku
  April 25, 2013

• Stivarga May Become Third/Forth-Line Colon Cancer Therapy in Japan: Prof. Sugihara
  April 25, 2013

• RA Treatment Guidelines to Reflect Patients’ Values and Economic Considerations as Well as Evidence
  April 24, 2013

ページ

• « 先頭
• ‹ Prev
• …
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• Next ›
• 最終 »